U.S. markets close in 3 hours 7 minutes
  • S&P 500

    4,048.85
    +31.08 (+0.77%)
     
  • Dow 30

    33,868.65
    +151.56 (+0.45%)
     
  • Nasdaq

    11,519.59
    +125.77 (+1.10%)
     
  • Russell 2000

    1,920.32
    +34.60 (+1.83%)
     
  • Crude Oil

    78.69
    +0.79 (+1.01%)
     
  • Gold

    1,945.20
    +6.00 (+0.31%)
     
  • Silver

    23.82
    +0.09 (+0.37%)
     
  • EUR/USD

    1.0870
    +0.0013 (+0.12%)
     
  • 10-Yr Bond

    3.5330
    -0.0180 (-0.51%)
     
  • GBP/USD

    1.2324
    -0.0030 (-0.24%)
     
  • USD/JPY

    130.2290
    -0.1290 (-0.10%)
     
  • BTC-USD

    23,169.46
    +1.65 (+0.01%)
     
  • CMC Crypto 200

    526.15
    +7.35 (+1.42%)
     
  • FTSE 100

    7,771.70
    -13.17 (-0.17%)
     
  • Nikkei 225

    27,327.11
    -106.29 (-0.39%)
     

Amgen Is The Underdog In Obesity Treatment — But It's Creeping Up On Novo Nordisk, Eli Lilly

Amgen Is The Underdog In Obesity Treatment — But It's Creeping Up On Novo Nordisk, Eli Lilly

Amgen stock dipped Thursday though the company unveiled promising results for its experimental obesity treatment.